Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance – CNBC

  1. Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance  CNBC
  2. Lilly’s (LLY) Sales Fall Short on Disappointing Zepbound Weight-Loss Drug Sales  Bloomberg
  3. Eli Lilly Q3 Earnings: Mounjaro Sales More Than Double, Takes $2.98 Billion Hit To Profit, Cuts Annual Outlook, Stock Tanks  Yahoo Finance
  4. Lilly misses sales forecast by $800M, lowers revenue guidance for the year  Endpoints News
  5. Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products  Investors | Eli Lilly and Company